Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in New Hampshire, automatically classified by Maddy, our AI policy reader.

Total bills
166
2026 Regular Session
Top supporter
David Rochefort
82% support rate
Top opponent
Donovan Fenton
27% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in New Hampshire

Legislators moving healthcare in New Hampshire
Legislator Party Stance Support rate Votes
David Rochefort
David Rochefort Senate · District 1
R
Strong +
82% 35
Tim Lang
Tim Lang Senate · District 2
R
Strong +
82% 35
Dan Innis
Dan Innis Senate · District 7
R
Strong +
82% 35
Victoria Sullivan
Victoria Sullivan Senate · District 18
R
Strong +
82% 35
James Gray
James Gray Senate · District 6
R
Strong +
82% 35
Donovan Fenton
Donovan Fenton Senate · District 10
D
Oppose
27% 35
Russ Dumais
Russ Dumais House · District Belknap 6
R
Oppose
27% 31
Pat Long
Pat Long Senate · District 20
D
Oppose
27% 35
Sue Prentiss
Sue Prentiss Senate · District 5
D
Oppose
27% 35
David Watters
David Watters Senate · District 4
D
Oppose
27% 35
Showing 91–100 of 166 bills

All healthcare bills

died · New Hampshire · House Feb 3, 2026

HB 1796: allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

HB 1796 creates a regulated program allowing the therapeutic use of psilocybin in clinical settings to treat specific medical conditions, including treatment-resistant depression, PTSD, substance use disorders, and end-of-life care. The bill requires the Department of Health and Human Services to establish a regulatory board and license qualified medical providers, cultivation facilities, and testing laboratories. It sets standards for administration sessions (including preparation, the session itself, and integration) and mandates reporting of adverse events. This program will make psilocybin treatment available to eligible patients under medical supervision in approved settings.
failed · New Hampshire · House Aug 5, 2026

HB 1656: relative to insurance coverage for pelvic health therapy.

HB 1656 requires all health insurance plans in New Hampshire to cover pelvic-floor physical therapy (PFPT) as a standard benefit for specific conditions, including urinary incontinence, pelvic organ prolapse, postpartum recovery, and pelvic pain. It mandates coverage for up to 12 weeks of supervised therapy, pre-surgery preparation (prehab), and post-surgery rehabilitation without prior authorization for initial evaluations. Insurers must report on this coverage data annually, and the insurance department will publish an annual report on insurer compliance. This directly affects residents with pelvic floor dysfunction, ensuring access to evidence-based treatments currently often excluded from coverage.
signed · New Hampshire · House Jun 2, 2026

HB 1356: relative to the statute of limitations for bringing a private right of action for violation of the statute prohibiting medical procedures and treatments intended to alter a minor's gender, authorizing the application of sunscreen in schools and camps without a licensed health care provider's note or prescription, and establishing a skin cancer prevention education program.

HB 1356 extends the statute of limitations for minors to sue providers for violating laws prohibiting gender-altering medical procedures. It changes the deadline from 2 years to 10 years after a minor turns 18 to file a private lawsuit. This directly affects minors who received such medical treatments before age 18 and wish to pursue legal action. The bill modifies RSA 332-N:3, II, which governs when claims for violations of the gender-procedure ban must be filed. The fiscal note indicates no state or local cost impact.
failed · New Hampshire · House Mar 5, 2026

HB 1782: relative to access to rural maternal health care and directing the department of health and human services to develop a rural maternal health care delivery pilot program.

HB 1782 establishes a rural maternal health care delivery pilot program to provide prenatal and postnatal care in New Hampshire areas with limited access to specialized pregnancy services. The bill directs the Department of Health and Human Services to develop this program, which would use mid-level practitioners (like certified nurse midwives) and collaborate with nearby hospitals, while also creating a Maternity Care Improvement Commission to study statewide maternal health strategies. It includes a Medicaid provider audit to ensure proper reimbursement for midwives and a loan reimbursement program for certified midwives who commit to working 32+ hours weekly in rural areas for at least two years. The pilot program and commission must report findings to state leaders by July 1, 2028. This bill directly affects rural pregnant people, midwives, and healthcare providers in underserved communities.
failed · New Hampshire · House Feb 19, 2026

HB 1038: establishing a committee to study raising awareness of the law providing immunity from liability in certain cases involving drug overdoses.

This bill creates a committee called the "better education on life-saving action committee" to study how to improve public awareness of New Hampshire's good Samaritan law. The law protects people from legal liability when they call for medical help during a drug overdose. The committee will examine current outreach methods, identify effective ways to reach high-risk communities, and assess whether state funding could help spread the information. It must report its findings and recommendations to state leaders by November 1, 2026.
Sub-Topics Substance Abuse
signed · New Hampshire · House Jul 10, 2026

HB 1705: establishing an employee assistance program for small town and volunteer first responders.

HB 1705 establishes a First Responders Support Fund to cover enrollment costs for small town and volunteer first responders into the state’s existing Employee Assistance Program (EAP). It directly affects first responders in communities with no more than 5 full-time paid staff, including volunteer departments. The fund, administered by the Department of Health and Human Services, uses state appropriations (initially $1 for FY 2026-2027) and accepts gifts, grants, or donations to cover EAP enrollment fees. The EAP provides mental health support, including services for PTSD, with the department required to report annually on fund usage and program outcomes. This bill does not create new services but expands access to an existing state EAP for eligible small-community responders.
Sub-Topics Mental Health
died · New Hampshire · House Mar 4, 2026

HB 1377: allowing parents to make alternative caregiver arrangements for their children without transferring guardianship.

This bill creates a formal process for parents and legal guardians to authorize specific caregivers (adults with whom a minor resides) to make education and health care decisions for children without transferring full guardianship. It establishes "Caregiver Authorization Affidavits" that must be notarized, include specific information about all parties, and be signed under oath with witnesses. The authorized caregiver can consent to medical treatment, access health records, and make educational decisions on behalf of the child, while the parent retains ultimate authority to override decisions. The authorization is valid for up to two years, cannot be used to circumvent laws or for specific school attendance, and can be amended or revoked in writing.
failed · New Hampshire · House Mar 5, 2026

HB 1769: relative to certain prohibitions on abortion referrals by publicly funded medical facilities.

HB 1769 prohibits publicly funded medical facilities (including state-funded hospitals and clinics) from referring patients for abortions, except in medical emergencies or when referring to a pregnancy resource center (a nonprofit facility offering counseling/support but not abortion services). The bill requires these facilities to submit compliance affidavits and allows taxpayers or affected mothers/family members to sue the facility or state for violations. It also voids contracts with organizations that violate the referral ban. This law directly affects state-funded healthcare providers and creates new legal avenues for challenging abortion referrals. The bill takes effect January 1, 2027.
Sub-Topics Women's Health
signed · New Hampshire · House Apr 22, 2026

HB 1160: relative to the county-state finance commission.

HB 1160 amends the structure and responsibilities of New Hampshire's county-state finance commission, which oversees shared funding between counties and the state for programs like Medicaid long-term care. The bill changes commission membership to include specific state agency representatives, county government appointees, and legislative members, while adding six new duties. Key provisions require the commission to review and recommend changes to Medicaid plans, state rate settings for long-term care services, county billing systems, and funding options before they are finalized. This directly affects counties and state agencies managing shared financial obligations for healthcare and social services programs.
failed · New Hampshire · House May 21, 2026

HB 1734: establishing a committee to study the feasibility of establishing experimental treatment centers in New Hampshire and the oversight thereof.

HB 1734 authorizes New Hampshire to establish experimental treatment centers that provide medical treatments using investigational drugs, biologics, or devices that have completed Phase 1 clinical trials but are not yet FDA-approved for general use. These centers must be approved by the Department of Health and Human Services and can only treat eligible patients who have a physician's recommendation, provided written informed consent (including discussion of alternative FDA-approved treatments and potential costs), and understand insurance may not cover the treatment. The bill creates a new legal framework distinct from existing medical licensing, requiring centers to follow specific consent protocols and safety standards documented by qualified medical institutions. It directly affects patients seeking innovative treatments, healthcare providers, and manufacturers of investigational medical products.
Showing 91 to 100 of 166 bills
Previous 1 9 10 11 17 Next